Srs Capital Advisors, Inc. Agios Pharmaceuticals, Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 122 shares of AGIO stock, worth $5,181. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122
Previous 14
771.43%
Holding current value
$5,181
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.3MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$240 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$233 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$206 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$165 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$118 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.33B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...